Ganeden Biotech, Inc. Report issue

For profit Phase 4
Founded: Ohio IL United States (1997)
Status: Acquired by Kerry (2017)

Organization Overview

First Clinical Trial
2008
NCT00881322
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree